DexCom, Inc. (LON:0A4M)

DexCom Statistics

Total Valuation

DexCom has a market cap or net worth of GBP 19.36 billion. The enterprise value is 18.91 billion.

Market Cap	19.36B
Enterprise Value	18.91B

Important Dates

The next estimated earnings date is Thursday, April 23, 2026.

Earnings Date	Apr 23, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	384.86M
Shares Outstanding	n/a
Shares Change (YoY)	-1.75%
Shares Change (QoQ)	-2.09%
Owned by Insiders (%)	0.37%
Owned by Institutions (%)	96.43%
Float	382.94M

Valuation Ratios

The trailing PE ratio is 31.16 and the forward PE ratio is 26.30.

PE Ratio	31.16
Forward PE	26.30
PS Ratio	5.59
PB Ratio	9.49
P/TBV Ratio	9.83
P/FCF Ratio	24.19
P/OCF Ratio	18.09
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.10, with an EV/FCF ratio of 23.63.

EV / Earnings	30.44
EV / Sales	5.42
EV / EBITDA	21.10
EV / EBIT	27.73
EV / FCF	23.63

Financial Position

The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.51.

Current Ratio	1.88
Quick Ratio	1.53
Debt / Equity	0.51
Debt / EBITDA	1.17
Debt / FCF	1.30
Interest Coverage	49.83

Financial Efficiency

Return on equity (ROE) is 34.50% and return on invested capital (ROIC) is 33.98%.

Return on Equity (ROE)	34.50%
Return on Assets (ROA)	8.89%
Return on Invested Capital (ROIC)	33.98%
Return on Capital Employed (ROCE)	21.72%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	313,472
Profits Per Employee	56,233
Employee Count	11,050
Asset Turnover	0.73
Inventory Turnover	3.18

Taxes

In the past 12 months, DexCom has paid 187.31 million in taxes.

Income Tax	187.31M
Effective Tax Rate	23.16%

Stock Price Statistics

The stock price has increased by +5.85% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+5.85%
50-Day Moving Average	77.10
200-Day Moving Average	82.50
Relative Strength Index (RSI)	46.61
Average Volume (20 Days)	10,343

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.14

Income Statement

In the last 12 months, DexCom had revenue of GBP 3.46 billion and earned 621.37 million in profits. Earnings per share was 1.55.

Revenue	3.46B
Gross Profit	2.08B
Operating Income	677.47M
Pretax Income	808.68M
Net Income	621.37M
EBITDA	864.55M
EBIT	677.47M
Earnings Per Share (EPS)	1.55

Balance Sheet

The company has 1.49 billion in cash and 1.04 billion in debt, with a net cash position of 447.51 million.

Cash & Cash Equivalents	1.49B
Total Debt	1.04B
Net Cash	447.51M
Net Cash Per Share	n/a
Equity (Book Value)	2.04B
Book Value Per Share	5.30
Working Capital	1.40B

Cash Flow

In the last 12 months, operating cash flow was 1.07 billion and capital expenditures -270.08 million, giving a free cash flow of 800.36 million.

Operating Cash Flow	1.07B
Capital Expenditures	-270.08M
Depreciation & Amortization	188.84M
Net Borrowing	-905.60M
Free Cash Flow	800.36M
FCF Per Share	n/a

Margins

Gross margin is 60.10%, with operating and profit margins of 19.56% and 17.94%.

Gross Margin	60.10%
Operating Margin	19.56%
Pretax Margin	23.35%
Profit Margin	17.94%
EBITDA Margin	24.96%
EBIT Margin	19.56%
FCF Margin	23.11%

Dividends & Yields

DexCom does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.75%
Shareholder Yield	1.75%
Earnings Yield	3.21%
FCF Yield	4.13%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 13, 2022. It was a forward split with a ratio of 4.

Last Split Date	Jun 13, 2022
Split Type	Forward
Split Ratio	4

Scores

DexCom has an Altman Z-Score of 7.06 and a Piotroski F-Score of 6.

Altman Z-Score	7.06
Piotroski F-Score	6